Guidelines for asbestos remediation at Italian superfund sites

Asbestos in soil and water: A review of analytical techniques and methods

In this review the main standard and novel analytical techniques and methods for sampling, sample preparation, detection and quantification of asbestos in soil and water are described, compared and discussed in terms of advantages and limitations. An overview of common analytical methods applied for identification and quantification of airborne asbestos is preliminary provided, as they have been widely studied, due to the well-known human pathologies related to fibers inhalation. Despite the presence of asbestos in soil and water may also constitute a health risk, it has been less investigated and regulated. For these environmental matrices, the methods adopted at international and national scale, covering the whole analytical process, from sampling to management of data, are reported in depth, highlighting their limitations like sensitivity, reliability and reproducibility. Finally, different promising novel/unconventional methods, that may substitute or support traditional ones for asbestos detection both in environmental and anthropic matrices, are presented and critically evaluated.

The Self-sustained High temperature Synthesis (SHS) technology as novel approach in the management of asbestos waste

The SHS technique was experimented in chrysotile breakdown. By means of two reactions such as Mg₃Si₂O₅(OH)₄ + Fe₂O₃ + 3 Mg and 2Mg₃Si₂O₅(OH)₄ + Fe₃O₄ + 4 Mg the chrysotile was completely converted into forsterite-rich olivine. Different mixtures of hematite + Mg and magnetite + Mg were tested with chrysotile to establish the maximum chrysotile amount in order to allow the reaction. In comparison with conventional thermal treatments, the SHS process is characterized by a fast reaction, needs low activation energy and the apparatus is simple. For these reasons, the asbestos neutralisation is carried out with positive balance of time and costs of the process. Furthermore, the combustion product can be re-used as secondary material.

Classification and management of asbestos-containing waste: European legislation and the Italian experience

OBJECTIVE

Production of a new classification of Asbestos Containing Products (ACPs), materials (ACM) and Asbestos Containing Waste (ACW), in addition to a correct identification of landfills where ACW should be disposed of in Europe.

METHODS

Analysis of the European and Italian legislation, study of waste classification and management in the main European countries, data analysis of mapping of Italian landfills and quantification of ACW disposed there.

FINDINGS

Classification according to unique criteria (physical state, substances with which asbestos minerals have been blended, function of the asbestos, etc.). Highlights of cases of incorrect management of ACW in Europe, specifying the Italian ones. Considering the significant inconsistencies between the European and national regulations and the actual implementation of those regulations, this paper provide some precise indications for the proper assignment to ACW of the European Waste Catalogue (EWC) codes. Lastly, suitable types of landfills at which ACW should be disposed of have been identified, in order to assisting the persons involved in ACW management to avoid undue exposition and their improper disposal.

CONCLUSION

This study reports a useful manual for classifying worldwide ACPs based on their physical state and considering the substances with which the asbestos minerals have been blended. Moreover several clear tables allow the asbestos remediation and waste management operators to suitably classify and dispose of ACW.

Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure

Asbestos exposure is known to cause lung cancer and mesothelioma and its health and economic impacts have been well documented. The exceptionally long latency periods of most asbestos-related diseases have hampered preventative and precautionary steps thus far. We aimed to summarize the state of knowledge on biomarkers of response to asbestos exposure. Asbestos is not present in human biological fluids; rather it is inhaled and trapped in lung tissue. Biomarkers of response, which reflect a change in biologic function in response to asbestos exposure, are analyzed. Several classes of molecules have been studied and evaluated for their potential utility as biomarkers of asbestos exposure. These studies range from small molecule oxidative stress biomarkers to proteins involved in immune responses.

An updated review on cancer risk associated with incretin mimetics and enhancers

Incretin-based therapies, including the use of incretin mimetics of glucagon-like peptide-1 receptor (GLP-1R) agonists and incretin enhancers of dipeptidyl-peptidase 4 (DPP-4) inhibitors, are widely used by clinicians for glucose lowering in patients with type 2 diabetes mellitus. These agents have benefits of a lower risk of hypoglycemia, being neutral for body weight for DPP-4 inhibitors and having a potential for weight reduction with GLP-1R agonists. They may also have a neutral or beneficial cardiovascular effect. Despite these benefits, an increased risk of cancer (especially pancreatic cancer and thyroid cancer) associated with incretin-based therapies has been reported. In this article, we reviewed related literature of experimental animal and observational human studies, clinical trials, and meta-analyses published until December 15, 2014. Current studies suggested a probable role of GLP-1R activation on the development of pancreatic cancer and thyroid cancer in rodents, but such an effect in humans is not remarkable due to the lower or lack of expression of GLP-1R on human pancreatic ductal cells and thyroid tissues. Findings in human studies are controversial and inconclusive. In the analyses of the US Food and Drug Administration adverse events reporting system, a significantly higher risk of pancreatic cancer was observed for GLP-1R agonists and DPP-4 inhibitors, but a significantly higher risk of thyroid cancer was only observed for GLP-1R agonists. Such a higher risk of pancreatic cancer or thyroid cancer could not be similarly demonstrated in other human observational studies or analyses of data from clinical trials. With regards to cancers other than pancreatic cancer and thyroid cancer, available studies supported a neutral association in humans. Some preliminary studies even suggested a potentially beneficial effect on the development of other cancers with the use of incretins. Based on current evidence, continuous monitoring of the cancer issues related to incretin-based therapies is required, even though the benefits may outweigh the potential cancer risk in the general patients with type 2 diabetes mellitus.

Diffuse Reflectance Infrared Fourier Transform Spectroscopy for the Determination of Asbestos Species in Bulk Building Materials

Diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy is a well-known technique for thin film characterization. Since all asbestos species exhibit intense adsorptions peaks in the 4000-400 cm^-1 region of the infrared spectrum, a quantitative analysis of asbestos in bulk samples by DRIFT is possible. In this work, different quantitative analytical procedures have been used to quantify chrysotile content in bulk materials produced by building requalification: partial least squares (PLS) chemometrics, the Linear Calibration Curve Method (LCM) and the Method of Additions (MoA). Each method has its own pros and cons, but all give affordable results for material characterization: the amount of asbestos (around 10%, weight by weight) can be determined with precision and accuracy (errors less than 0.1).

A review on thiazolidinediones and bladder cancer in human studies

There is a concern of an increased risk of bladder cancer associated with the use of thiazolidinediones, a class of oral glucose-lowering drugs commonly used in patients with type 2 diabetes with a mechanism of improving insulin resistance. Human studies on related issues are reviewed, followed by a discussion on potential concerns on the causal inference in current studies. Pioglitazone and rosiglitazone are discussed separately, and findings from different geographical regions are presented. Randomized controlled trials designed for primarily answering such a cancer link are lacking, and evidence from clinical trials with available data for evaluating the association may not be informative. Observational studies have been reported with the use of population-based administrative databases, single-hospital records, drug adverse event reporting system, and case series collection. Meta-analysis has also been performed by six different groups of investigators. These studies showed a signal of higher risk of bladder cancer associated with pioglitazone, especially at a higher cumulative dose or after prolonged exposure; however, a weaker signal or null association is observed with rosiglitazone. In addition, there are some concerns on the causal inference, which may be related to the use of secondary databases, biases in sampling, differential detection, and confounding by indications. Lack of full control of smoking and potential biases related to study designs and statistical approaches such as prevalent user bias and immortal time bias may be major limitations in some studies. Overlapping populations and opposing conclusions in studies using the same databases may be of concern and weaken the reported conclusions of the studies. Because randomized controlled trials are expensive and unethical in providing an answer to this cancer issue, observational studies are expected to be the main source in providing an answer in the future. Furthermore, international comparison studies using well-designed and uniform methodology to clarify the risk in specific sexes, ethnicities, and other subgroups and to evaluate the interaction with other environmental risk factors or medications will be helpful to identify patients at risk.

Arsenic, asbestos and radon: emerging players in lung tumorigenesis

The cause of lung cancer is generally attributed to tobacco smoking. However lung cancer in never smokers accounts for 10 to 25% of all lung cancer cases. Arsenic, asbestos and radon are three prominent non-tobacco carcinogens strongly associated with lung cancer. Exposure to these agents can lead to genetic and epigenetic alterations in tumor genomes, impacting genes and pathways involved in lung cancer development. Moreover, these agents not only exhibit unique mechanisms in causing genomic alterations, but also exert deleterious effects through common mechanisms, such as oxidative stress, commonly associated with carcinogenesis. This article provides a comprehensive review of arsenic, asbestos, and radon induced molecular mechanisms responsible for the generation of genetic and epigenetic alterations in lung cancer. A better understanding of the mode of action of these carcinogens will facilitate the prevention and management of lung cancer related to such environmental hazards.